Searched for
INDIAN PHARMACEUTICAL MARKET
Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...- Indian envoy pitches greater pharma exports, Chinese investment to deepen tiesIndia's ambassador to China, Vikram Doraiswami, stressed the importance of expanding access to Chinese markets for Indian pharmaceutical co...
- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Beyond China, beyond tariffs: India, Japan look to MSMEs to turn strategic ties into factory-floor partnershipsAs Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- India-UK trade pact sparks rush of export orders ahead of July 15 rolloutIndian exporters are experiencing a significant surge in UK orders ahead of the July 15th India-UK CETA implementation. Anticipating tariff...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Why did market rise today? Sensex gains 444 points, Nifty closes above 24,000. 3 key factorsIndian stock markets surged on Wednesday, breaking a two-day losing spell. Positive global sentiment and other factors propelled investor c...
- Lower crude, easing FII selling brighten market outlook; large-cap financials offer better value: Kunal VoraIndian equities are poised for a brighter outlook as crude oil prices retreat, corporate earnings show resilience, and foreign investor sel...
- Sensex rises over 150 points, Nifty above 23,900 as investors weigh Iran tensions, weak monsoon concernsIndian stock markets opened the second half of 2026 with modest gains after recent declines. Investors are closely watching escalating US-I...
- India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...
Load More
